Is Delta 8 THC legal in Kentucky?
Kentucky – On March 25, 2021, the Governor of Kentucky approved and signed House Bill 307, declaring that marijuana “means all parts of the plant Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant,” effectively outlawing all isomers of THC, including Delta-8. Furthermore, on April 19, 2021, the Kentucky Department of Agriculture sent a guidance letter to hemp license holders reiterating their position on D8 and even purports that D8 is a schedule I controlled substance under federal law.
KRS 260.850 TO 260.869 INDUSTRIAL HEMP
(5) “Industrial hemp” means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis;
(6) “Industrial hemp products” means products derived from, or made by, processing industrial hemp plants or plant parts;
Legal document found HERE
40 KRS 218A.010
218A.010 Definitions for chapter.
(27) “Marijuana” means all parts of the plant Cannabis sp., whether growing or not; the seeds thereof; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin or any compound, mixture, or preparation which contains any quantity of these substances. The term “marijuana” does not include:
(a) Industrial hemp that is in the possession, custody, or control of a person who holds a license issued by the Department of Agriculture permitting that person to cultivate, handle, or process industrial hemp;
(b) Industrial hemp products that do not include any living plants, viable seeds, leaf materials, or floral materials;
(c) The substance cannabidiol, when transferred, dispensed, or administered pursuant to the written order of a physician practicing at a hospital or clinic affiliated with a Kentucky public university having a college or school of medicine;
(d) For persons participating in a clinical trial or in an expanded access program, a drug or substance approved for the use of those participants by the United States Food and Drug Administration;
(e) A cannabidiol product derived from industrial hemp, as defined in KRS 260.850; or
(f) A cannabidiol product approved as a prescription medication by the United States Food and Drug Administration;
Legal document found HERE